Literature DB >> 7485314

Head entrapment and neonatal outcome by mode of delivery in breech deliveries from twenty-four to twenty-seven weeks of gestation.

P A Robertson1, C M Foran, M S Croughan-Minihane, S J Kilpatrick.   

Abstract

OBJECTIVES: Our purpose was to determine whether there are differences in the incidence of head entrapment and adverse neonatal outcome by mode of delivery in breech deliveries from 24 to 27 weeks of gestation. STUDY
DESIGN: Charts of 132 viable consecutive singleton breech deliveries from 24 to 27 weeks' gestation were reviewed. Statistical methods used included chi 2, logistic regression, and analysis of variance.
RESULTS: Head entrapment occurred in four of 43 (9.3%) vaginally delivered neonates and five of 89 (5.6%) neonates delivered by cesarean section (p = 0.17). The only identifiable risk factor for head entrapment was the birth weight category 1000 to 1249 gm (odds ratio 6.4, 95% confidence interval 1.6 to 26.1). There were no statistically significant associations between head entrapment and adverse neonatal outcomes.
CONCLUSIONS: There did not appear to be a difference in the incidence of head entrapment by mode of delivery for breech infants at 24 to 27 weeks' gestation, nor did there appear to be a difference in adverse neonatal outcomes after entrapment. However, this latter conclusion has limited power because of the small number of head entrapment cases.

Entities:  

Mesh:

Year:  1995        PMID: 7485314     DOI: 10.1016/0002-9378(95)91347-5

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Sarah J. Kilpatrick, MD, PhD, Editor for AJOG.

Authors:  Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2019-05       Impact factor: 8.661

2.  Maternal and infant morbidity following birth before 27 weeks of gestation: a single centre study.

Authors:  Andrei S Morgan; Saadia Waheed; Shivani Gajree; Neil Marlow; Anna L David
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.